Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease
Authors
Keywords
Supplemental Appendix, Background Mortality, Moderate Fibrosis, Early Stage Liver Disease, Increase Background Mortality
Journal
Applied Health Economics and Health Policy
Volume 15, Issue 1, Pages 65-74
Publisher
Springer Nature
Online
2016-08-01
DOI
10.1007/s40258-016-0261-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rising Mortality Associated With Hepatitis C Virus in the United States, 2003–2013
- (2016) Kathleen N. Ly et al. CLINICAL INFECTIOUS DISEASES
- Cost-effectiveness of treating chronic hepatitis C virus with direct-acting antivirals in people who inject drugs in Australia
- (2016) Nick Scott et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
- (2016) Natasha K. Martin et al. JOURNAL OF HEPATOLOGY
- Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals
- (2016) Jagpreet Chhatwal et al. PHARMACOECONOMICS
- Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population
- (2016) Harinder S. Chahal et al. JAMA Internal Medicine
- Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection
- (2015) Z. M. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Estimating the Number of Patients Infected With Chronic HCV in the United States Who Meet Highest or High-Priority Treatment Criteria
- (2015) Fujie Xu et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States
- (2015) Jagpreet Chhatwal et al. ANNALS OF INTERNAL MEDICINE
- Cost-effectiveness of Interferon-free therapy for Hepatitis C in Germany - an application of the efficiency frontier approach
- (2015) Christian Gissel et al. BMC INFECTIOUS DISEASES
- All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C Virus
- (2015) Fujie Xu et al. CLINICAL INFECTIOUS DISEASES
- Boceprevir for Chronic Genotype 1 Hepatitis C Virus in the Current Health Care Setting in Greece: A Cost-effectiveness Analysis
- (2015) Kostas Athanasakis et al. CLINICAL THERAPEUTICS
- A cost-effectiveness model to personalize antiviral therapy in naive patients with genotype 1 chronic hepatitis C
- (2015) Sergio Iannazzo et al. DIGESTIVE AND LIVER DISEASE
- Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes
- (2015) Hamish A. Innes et al. HEPATOLOGY
- Cost-effectiveness of new antiviral regimens for treatment-naïve U.S. veterans with hepatitis C
- (2015) Alexis P. Chidi et al. HEPATOLOGY
- Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease
- (2015) Andrew J. Leidner et al. HEPATOLOGY
- How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries
- (2015) Dorothée Obach et al. HEPATOLOGY
- Is antenatal screening for hepatitis C virus cost-effective? A decade’s experience at a London centre
- (2015) Nowlan Selvapatt et al. JOURNAL OF HEPATOLOGY
- Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006–2010
- (2015) Robert D. Allison et al. JOURNAL OF HEPATOLOGY
- Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients
- (2015) J. V. Fernández-Montero et al. JOURNAL OF VIRAL HEPATITIS
- Cost-effectiveness of sofosbuvir for the treatment of chronic hepatitis C-infected patients
- (2015) S. Cure et al. JOURNAL OF VIRAL HEPATITIS
- Cost-Effectiveness Modelling of Sofosbuvir-Containing Regimens for Chronic Genotype 5 Hepatitis C Virus Infection in South Africa
- (2015) Ilanca Fraser et al. PHARMACOECONOMICS
- Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada
- (2015) A. Moshyk et al. JOURNAL OF MEDICAL ECONOMICS
- Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naïve chronic hepatitis C genotype 1 patients in Japan
- (2015) Hiroyo Kuwabara et al. JOURNAL OF MEDICAL ECONOMICS
- A cost utility analysis of simeprevir used with peginterferon + ribavirin in the management of genotype 1 hepatitis C virus infection, from the perspective of the UK National Health Service
- (2015) Kirsten Westerhout et al. JOURNAL OF MEDICAL ECONOMICS
- Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy
- (2015) Sandrine Cure et al. JOURNAL OF MEDICAL ECONOMICS
- Cost-Effectiveness Analysis of Sofosbuvir Compared to Current Standard Treatment in Swiss Patients with Chronic Hepatitis C
- (2015) Alena M. Pfeil et al. PLoS One
- Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis c Genotype 1b Naïve Patients in Chile
- (2015) Constanza L. Vargas et al. PLoS One
- Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs
- (2014) Bruce R. Schackman et al. ADDICTION
- Cost-effectiveness of boceprevir co-administration versus peginterferon alpha-2b and ribavirin only for patients with hepatitis C genotype 1 in Singapore
- (2014) Yock Young Dan et al. ANTIVIRAL THERAPY
- Mortality Among Persons in Care With Hepatitis C Virus Infection: The Chronic Hepatitis Cohort Study (CHeCS), 2006-2010
- (2014) R. Mahajan et al. CLINICAL INFECTIOUS DISEASES
- Effectiveness and Cost-effectiveness of Immediate Versus Delayed Treatment of Hepatitis C Virus–Infected Patients in a Country With Limited Resources: The Case of Egypt
- (2014) Dorothée Obach et al. CLINICAL INFECTIOUS DISEASES
- Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C
- (2014) Salvatore Petta et al. DIGESTIVE AND LIVER DISEASE
- All-Cause Mortality and Liver-Related Outcomes Following Successful Antiviral Treatment for Chronic Hepatitis C
- (2014) Eric Dieperink et al. DIGESTIVE DISEASES AND SCIENCES
- Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection
- (2014) Yao-Chun Hsu et al. GUT
- Hospitalizations And Costs Associated With Hepatitis C And Advanced Liver Disease Continue To Increase
- (2014) Fujie Xu et al. HEALTH AFFAIRS
- The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation
- (2014) Debbie Hartwell et al. HEALTH TECHNOLOGY ASSESSMENT
- Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C
- (2014) Salvatore Petta et al. HEPATOLOGY
- Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C
- (2014) Emmanuel A. Tsochatzis et al. HEPATOLOGY
- Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individuals
- (2014) Liesl M. Hagan et al. HEPATOLOGY
- Regression of Hodgkin Lymphoma in Response to Antiviral Therapy for Hepatitis C Virus Infection
- (2014) Ken Takahashi et al. INTERNAL MEDICINE
- Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141)
- (2014) Sylvie Deuffic-Burban et al. JOURNAL OF HEPATOLOGY
- Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis C
- (2014) H. Leleu et al. JOURNAL OF VIRAL HEPATITIS
- Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options
- (2014) P. A. Cortesi et al. JOURNAL OF VIRAL HEPATITIS
- Cost-effectiveness of Telaprevir Combination Therapy for Chronic Hepatitis C
- (2014) Anita J. Brogan et al. PLoS One
- Cost-Effectiveness of Telaprevir in Patients with Genotype 1 Hepatitis C in Australia
- (2014) Emma Warren et al. VALUE IN HEALTH
- Cost Utility of Telaprevir–PR (Peginterferon–Ribavirin) Versus Boceprevir–PR and Versus PR Alone in Chronic Hepatitis C in The Netherlands
- (2014) Aikaterini Vellopoulou et al. Applied Health Economics and Health Policy
- Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems
- (2013) Daniel Fuster et al. ADDICTION
- New Protease Inhibitors for the Treatment of Chronic Hepatitis C
- (2013) Shan Liu et al. ANNALS OF INTERNAL MEDICINE
- Cost Effectiveness of Direct-Acting Antiviral Therapy for Treatment-Naive Patients With Chronic HCV Genotype 1 Infection in the Veterans Health Administration
- (2013) Kee Chan et al. Clinical Gastroenterology and Hepatology
- Cost-effectiveness of Screening for Chronic Hepatitis C Infection in the United States
- (2013) Mark H. Eckman et al. CLINICAL INFECTIOUS DISEASES
- Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients
- (2013) Yao-Chun Hsu et al. HEPATOLOGY
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
- (2013) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C
- (2013) Calogero Cammà et al. JOURNAL OF HEPATOLOGY
- All-oral, interferon-free treatment for chronic hepatitis C: cost-effectiveness analyses
- (2013) L. M. Hagan et al. JOURNAL OF VIRAL HEPATITIS
- Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients
- (2013) Antonio Blázquez-Pérez et al. PHARMACOECONOMICS
- Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Screening for Chronic Hepatitis C Infection in the United States
- (2013) Shan Liu et al. PLoS One
- Is Adding HCV Screening to the Antenatal National Screening Program in Amsterdam, The Netherlands, Cost-Effective?
- (2013) Anouk T. Urbanus et al. PLoS One
- Cost-Effectiveness of Boceprevir in Patients Previously Treated for Chronic Hepatitis C Genotype 1 Infection in the United States
- (2013) Jagpreet Chhatwal et al. VALUE IN HEALTH
- Economic Assessment of an Anti-HCV Screening Program in Italy
- (2013) Matteo Ruggeri et al. VALUE IN HEALTH
- Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in treatment-experienced chronic hepatitis C genotype 1 patients
- (2013) Sandrine Cure et al. JOURNAL OF MEDICAL ECONOMICS
- Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in previously untreated chronic hepatitis C genotype 1 patients
- (2013) Sandrine Cure et al. JOURNAL OF MEDICAL ECONOMICS
- Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal
- (2013) Elamin H. Elbasha et al. Applied Health Economics and Health Policy
- Cost-effectiveness and Population Outcomes of General Population Screening for Hepatitis C
- (2012) Phillip O. Coffin et al. CLINICAL INFECTIOUS DISEASES
- Sustained Virological Response to Interferon Plus Ribavirin Reduces Non-Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus
- (2012) J. Berenguer et al. CLINICAL INFECTIOUS DISEASES
- Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C
- (2012) Calogero Cammà et al. HEPATOLOGY
- Assessing the cost-effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia
- (2012) Adam J Visconti et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study
- (2012) M.-H. Lee et al. JOURNAL OF INFECTIOUS DISEASES
- Cost-Effectiveness of Truncated Therapy for Hepatitis C Based on Rapid Virologic Response
- (2012) Ziad F. Gellad et al. VALUE IN HEALTH
- A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C
- (2011) Lisa I. Backus et al. Clinical Gastroenterology and Hepatology
- All-Cause, Liver-Related, and Non-Liver-Related Mortality Among HCV-Infected Individuals in the General US Population
- (2011) S. S. El-Kamary et al. CLINICAL INFECTIOUS DISEASES
- Economic model of a birth cohort screening program for hepatitis C virus
- (2011) Lisa J. McGarry et al. HEPATOLOGY
- Pregnancy outcomes associated with viral hepatitis
- (2011) K. L. B. Reddick et al. JOURNAL OF VIRAL HEPATITIS
- Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients
- (2011) Shan Liu et al. PLoS One
- Structural Frameworks and Key Model Parameters in Cost-Effectiveness Analyses for Current and Future Treatments of Chronic Hepatitis C
- (2011) Rebecca Townsend et al. VALUE IN HEALTH
- Manifestations of Chronic Hepatitis C Virus Infection Beyond the Liver
- (2010) Ira M. Jacobson et al. Clinical Gastroenterology and Hepatology
- Increased Mortality Among Persons Infected With Hepatitis C Virus
- (2010) Lars Haukali Omland et al. Clinical Gastroenterology and Hepatology
- Increased All-Cause, Liver, and Cardiac Mortality among Hepatitis C Virus-seropositive Blood Donors
- (2008) Anne M. Guiltinan et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now